Venus Remedies Ltd rallies on strategic tie-up with Teva

 

 Venus Remedies Ltd rallied as much as 13.9 per cent in trade on Wednesday, after the pharma major said it has entered into a collaborative agreement with Israel-based generic drug marker Teva for selling an anti- cancer drug in the Canadian market.                             
BSE Code -  526953
Face Value - Rs 10
Group - BSE 'B'
Shareholding pattern- (a)Promoters- 37.73%
                                 (b)Institutions- 8.69%
                                 (c)Non-Institutions- 53.58%
One year High-Low - Rs 350 - Rs 163
     Venus Remedies Ltd currently trading at Rs 298.00, up by 40.40 points from its previous closing of Rs 257.60 on the BSE